
![]() |
|||||||||||||
WJPR Citation Report
|
| All | Since 2021 | |
| Citation | 9186 | 4781 |
| h-index | 32 | 25 |
| i10-index | 256 | 108 |
A CONCEPTUAL REVIEW ARTICLE ON TAMAKA SHWASA (BRONCHIAL ASTHMA)
Dr. Asmita Rani*, Prof. (Dr.) Ravi Sharma
Abstract Bronchial asthma remains one of the most prevalent chronic non-communicable respiratory conditions worldwide, and its long-term management with bronchodilators and corticosteroids continues to raise concerns around dose dependency and adverse effects. Ayurveda's classical description of Tamaka Shwasa offers a disease model built on Vata-Kapha vitiation within Pranavaha Srotas that maps in striking, though not exact, correspondence onto the modern understanding of reversible airway obstruction. This review revisits the classical construction of Tamaka Shwasa — its Nidana, Samprapti, Purvarupa and Rupa — and reads it against the extrinsic/intrinsic classification of bronchial asthma described in contemporary pulmonary medicine, with particular attention to where the two frameworks converge (a two-humor, biphasic model of airway narrowing) and where they diverge (the classical inclusion of Pitta at the site of origin versus the immunological IgE-mediated basis identified in modern pathology). The review argues that the value of this comparison lies less in establishing a one-to-one equivalence between the two systems and more in showing how each supplies an explanatory layer the other does not: Ayurveda's staged, causal Kriyakala model for tracing when in the disease course intervention is most effective, and modern immunology's account of the specific inflammatory mediators responsible for bronchoconstriction and remodeling. Keywords: Tamaka Shwasa, Bronchial Asthma, Pranavaha Srotas, Ayurveda integrative respiratory medicine. [Full Text Article] [Download Certificate] |
